An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
NCT01316679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2017-04-12
Summary
Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.
Conditions
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
More Related Trials
-
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
NCT05327907 ·Status: UNKNOWN
-
The Utility of Breath Biopsy as a Screening Tool for HCC
NCT04326491 ·Status: COMPLETED
-
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
NCT04414956 ·Status: RECRUITING ·Phase: NA
-
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
NCT04221347 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 ·Status: COMPLETED
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
NCT03894917 ·Status: RECRUITING
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
NCT00709085 ·Status: UNKNOWN
-
Clinical Trial Multi-analyte Blood Test
NCT03694600 ·Status: UNKNOWN
-
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
NCT03722628 ·Status: UNKNOWN
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease
NCT06871930 ·Status: NOT_YET_RECRUITING
-
Tumor Growth Factors in Hepatocellular Carcinoma
NCT00764140 ·Status: COMPLETED
-
A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
NCT02272504 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Hepatocellular Cancer (HCC) Screening in Zhongshan City
NCT02501980 ·Status: UNKNOWN
-
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
NCT06899087 ·Status: RECRUITING
-
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis
NCT03318380 ·Status: COMPLETED ·Phase: NA
-
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
NCT05719480 ·Status: RECRUITING
-
Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
NCT06994130 ·Status: NOT_YET_RECRUITING
-
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
NCT00912847 ·Status: COMPLETED
-
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
NCT02288910 ·Status: COMPLETED